-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The latest news said that the first batch of joint procurement of traditional Chinese medicine pieces in the country has entered the stage of enterprise quotation, and the results of bid opening will be just around
the corner.
This batch of Chinese medicine pieces covered 15 provinces (municipalities and districts), and a total of 21 varieties were included, including many of the top 20 best-selling products
in China's urban pharmacies in 2021, such as astragalus, honeysuckle and angelica.
An authoritative report in the industry revealed that the processing market size of traditional Chinese medicine pieces in 2021 has exceeded 200 billion yuan
.
Under the background of Chinese medicine innovation and modernization, Chinese medicine pieces will be guided by the joint procurement mechanism of "high quality and good price" to promote the overall "quality and upgrading" of Chinese medicine, and promote the high-quality development of
Chinese medicine.
The first batch of Chinese medicine pieces was jointly harvested, with 21 varieties piloted and the purchase volume exceeded 5,000 tons
For a long time, there have been pain points in the industry such as large quality differences, high price fluctuations, unstable supply, and irregular production and circulation markets.
At the beginning of this year, in response to the call of the National Health Insurance Administration, Shandong and 11 provinces (cities) jointly led and established the Sanming Procurement Alliance Inter-provincial Traditional Chinese Medicine (Materials) Procurement Alliance (hereinafter referred to as the "Alliance") to carry out cross-regional normalized joint procurement of Chinese medicines (materials) and realize the "quality assurance, upgrading and stable supply" of the supply of traditional Chinese medicines (materials)
in the alliance provinces and cities.
In March and November 2022, the Alliance issued notices on the joint procurement of Chinese medicine pieces and formal procurement documents (hereinafter referred to as the "Documents"
).
Recently, the alliance issued a notice on the declaration of enterprises for joint procurement of traditional Chinese medicine pieces, which means that the first batch of joint procurement of traditional Chinese medicine pieces in the country that has been preparing for nearly 9 months is about to enter the stage of opening
bids 。
Source: Sanming Purchasing Alliance (Nationwide) official website
Fifteen provinces (municipalities and districts) participated in the joint procurement of Chinese medicine pieces, including Shandong, Shanxi, Inner Mongolia, Jilin, Heilongjiang, Anhui, Fujian, Jiangxi, Hunan, Yunnan, Tibet, Qinghai, Ningxia, Xinjiang and the Xinjiang Production and Construction Corps
。
The 21 Chinese herbal tablets were the first to be piloted, namely astragalus, codonopsis tablets, honeysuckle, angelica, bran fried white art, safflower, scalding leech, Mai dong, huanglian tablets, prince ginseng, white peony, licorice tablets, earth dragon, Chuanxiong, danshen, huangzen tablets, yam, dandelion, peony peel and bellflower
.
From the perspective of the agreed purchase volume in the first year, the agreed purchase volume (selection + unified goods) of one product of astragalus alone exceeded 800 tons, and the total agreed purchase volume of 21 varieties in the first year exceeded 5,000 tons
.
List of products for joint procurement of Chinese herbal tablets
Source: Sanming Purchasing Alliance (nationwide) official website, Minai net collation
Due to the large number of specifications of Chinese medicine pieces, the joint procurement of two product specifications is divided into two kinds of goods and unified goods, which is expected to force the product selection of Chinese medicine pieces enterprises and medical institutions, or further improve the quality level of Chinese medicine pieces and improve the problem
of large differences in the quality of Chinese medicine pieces.
(Note: The selection can be understood as the type of drinking pieces with relatively high specifications; Unified goods can be understood as pieces purchased or sold at a uniform price regardless of quality, specification and grade
.
）
3 core highlights: stricter standards, easier selection, and gentler price reductions
From the perspective of selection rules and quotation requirements, there are three core highlights of this joint procurement of Chinese medicine pieces: stricter standards, easier selection, and gentler price reduction
.
According to the requirements of the documents, the effective declaration of enterprise unified goods and selection of goods will be reviewed and grouped, and one product specification will be a review group
.
If there are less than 3 valid declaration enterprises in the same review team, the procurement
of this product specification will be canceled.
The selected drugs to be selected in joint procurement shall be determined
through two links: comprehensive review and bidding and quotation.
Among them, the comprehensive review process focuses on the variety supply capacity, planting (breeding) base, traceability system, alliance procurement demand, alliance medical institution coverage, production management ability, quality control ability, as well as supply guarantee commitment, authentic medicinal materials, GAP base and other indicators, and the price score item accounts for 15 points, which is one-eighth
of the total score of 120.
Comprehensive review index scoring items
Source: Sanming Purchasing Alliance (nationwide) official website, Minai net collation
At the same time, the shortlisted enterprises should submit product samples, and the expert group will conduct the compliance inspection of the quality level, and if they do not meet the requirements, they will be disqualified from the shortlisted; Those that meet the requirements should also be kept for subsequent inspection, which puts forward higher requirements
for the quality standards of Chinese medicine pieces.
Subsequently, according to the ranking of the valid reporting enterprises, the list of
enterprises shortlisted in the bidding and quotation stage is determined.
The maximum number of shortlisted enterprises is determined according to the number of enterprises effectively declared by the same review group, when the number of eligible enterprises is 6 or less, the probability of enterprises being shortlisted is the largest, and even "zero elimination" shortlisted, after 19 and above, the probability of enterprises being shortlisted directly drops to about
30%.
The maximum number of shortlisted auction companies
Source: Sanming Purchasing Alliance (nationwide) official website, Minai net collation
The second round of quotation after the comprehensive review mainly focuses on all the shortlisted products of each review team
.
The second round of quotations must not be higher than the highest valid declared price and its first round quotation, and those exceeding them will be regarded as invalid quotations and will be disqualified
from shortlisting.
The determination of the selected drugs only needs to meet: (1) the price reduction range ≥ 20%; (2) The quotation spread ≤ 1.
2 times the minimum declared price of any one condition can be selected
.
Compared with the winning requirements of national procurement (1.
8 times circuit breaker mechanism, 5≥0% reduction and comparable price ≤0.
1), the price reduction of Chinese medicine pieces is milder and the difficulty of selection is relatively easy
。
The 200 billion market pattern has changed, astragalus, honeysuckle, angelica.
.
.
Best-selling products are listed
By comparing the volume reports of each alliance and combining the maximum limit price of each variety, the total purchase amount of the 21 shortlisted Chinese medicine pieces joint procurement was about 750 million yuan, involving five major categories of drugs: deficiency medicine, antipyretic medicine, blood circulation and stasis removal medicine, liver quenching medicine and phlegm cough and asthma medicine, among which, astragalus, honeysuckle and angelica ranked eighth, tenth, fifteenth and eighteenth
respectively in the TOP20 of terminal products in China's urban physical pharmacies in 2021 。
Joint procurement of traditional Chinese medicine pieces terminal sales in physical pharmacies in Chinese cities in 2021 (: 100 million yuan)
Note: Less than $100 million is indicated by *
Source: Minai.
com: China's urban physical pharmacy drug terminal competition pattern
In fact, there are more than ten manufacturers of traditional Chinese medicine pieces included in the above-mentioned joint procurement, and some of the inflated prices of products can be squeezed out through market competition
.
Obviously, price reduction is not the key indicator of the joint procurement of Chinese medicine pieces, and it may be its fundamental purpose
to improve product quality and standardize market order through multiple comprehensive screening.
With the advent of the era of innovation and modernization of traditional Chinese medicine, coupled with the promotion of favorable national policies, the development of the traditional Chinese medicine tablet industry has steadily increased
in recent years.
According to data from Minai.
com, the sales scale of terminal traditional Chinese medicine pieces in China's urban physical pharmacies in 2021 has exceeded 25 billion yuan, a year-on-year increase of 3.
8%, and it is expected to maintain a high level in 2022, with sales revenue of about 24 billion yuan
.
In addition, according to the "2021 China Pharmaceutical Industry Economic Operation Report", the processing market size of traditional Chinese medicine pieces in 2021 will exceed 200 billion yuan, and the market potential is very huge
。
Sales Trend of Traditional Chinese Medicine Pieces in China's Urban Physical Pharmacy Terminal (: 100 million yuan)
Source: Minai.
com: China's urban physical pharmacy drug terminal competition pattern
Chinese medicine pieces have entered the era of "high quality and competitive price", driving the sustainable development of Chinese medicine innovation
Different from Western medicine, Chinese medicine pieces need to carry out strict quality control from the planting and harvesting of raw materials to the processing of drinking pieces to ensure "high quality", and the cost of good and inferior pieces is also very
different.
The inter-provincial joint procurement of Chinese medicine pieces will be guided by the "high quality and competitive price" mechanism, promote the overall "quality and upgrading" of Chinese medicine, and help the high-quality development of
Chinese medicine.
With the development of joint procurement of traditional Chinese medicine pieces, it is expected that the entire market will be reshuffled, small and medium-sized enterprises that do not meet the conditions will be eliminated, and enterprises with strong strength will become bigger
and bigger.
Under the pressure of joint mining, Chinese medicine pieces manufacturers are expected to form healthy competition and further improve the quality of products in the
entire industry.
At present, listed companies related to Chinese medicine pieces have also received attention from the industry, such as China Resources Sanjiu, China Traditional Chinese Medicine and Xiangxue Pharmaceutical, etc.
, and their businesses are all involved in the production of
Chinese medicine pieces.
Previously, according to China Resources Sanjiu, the centralized procurement of proprietary Chinese medicines may further expand in the next few years, but considering that the company's prescription drug business accounts for a large proportion of exclusive varieties, and the sales expenses of centralized procurement products will further decline, which may bring stability or growth in sales, the profitability of traditional Chinese medicines is guaranteed
to a certain extent.
The first batch of joint procurement of Chinese medicine pieces in China will be a good opportunity to jointly promote product quality, price, supply and other management innovation, aiming to promote the formation of a virtuous circle in the industry with "quality assurance, upgrading and stable supply", and play a fundamental role in promoting the healthy development of the traditional Chinese medicine industry
.
Chen Jinfu, former deputy director of the National Health Insurance Administration, once said that the rules for centralized procurement of drugs will not be "only low price" <B142>。 Based on the particularity of traditional Chinese medicine, "high quality and high price" will become the vane
for the layout and development of traditional Chinese medicine pieces enterprises in the future.
Source: Minainet database, Sanming Purchasing Alliance (nationwide) official website
Note: Minai.
com's "Competition Pattern of Drug Terminal in China's Urban Physical Pharmacies", the statistical scope is: physical pharmacies in cities at the prefecture level and above nationwide, excluding county and rural pharmacies; All sales are based on the average retail price of the product
.
Data statistics as of November 30, if there is any omission, welcome to correct!
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). 
